Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Nonneoplastic Cystic Lesions of the Central Nervous System-Histomorphological Spectrum: A Study of 538 Cases.

Bhatt AS, Mhatre R, Nadeesh BN, Mahadevan A, Yasha TC, Santosh V.

J Neurosci Rural Pract. 2019 Jul;10(3):494-501. doi: 10.1055/s-0039-1698033. Epub 2019 Oct 7.

2.

Medulloblastoma: Distinctive Histo-Molecular Correlation with Clinical Profile, Radiologic Characteristics, and Surgical Outcome.

Narayan V, Sugur H, Jaiswal J, Arvinda HR, Arivazhagan A, Somanna S, Santosh V.

Pediatr Neurosurg. 2019;54(5):329-340. doi: 10.1159/000501913. Epub 2019 Sep 3.

PMID:
31480064
3.

Gene Expression in Intracranial Aneurysms-Comparison Analysis of Aneurysmal Walls and Extracranial Arteries with Real-Time Polymerase Chain Reaction and Immunohistochemistry.

Tyagi G, Srinivas D, Nanjaiah ND, Purushottam M, Somanna S, Santosh V, Jain S.

World Neurosurg. 2019 Oct;130:e117-e126. doi: 10.1016/j.wneu.2019.06.002. Epub 2019 Jun 13.

PMID:
31371266
4.

Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma.

Kruthika BS, Sugur H, Nandaki K, Arimappamagan A, Paturu K, Santosh V.

J Clin Pathol. 2019 Oct;72(10):677-681. doi: 10.1136/jclinpath-2019-205834. Epub 2019 Jul 3.

PMID:
31270134
5.

H3K27M, IDH1, and ATRX expression in pediatric GBM and their clinical and prognostic significance.

Uppar AM, Sugur H, Prabhuraj AR, Rao MB, Devi BI, Sampath S, Arivazhagan A, Santosh V.

Childs Nerv Syst. 2019 Sep;35(9):1537-1545. doi: 10.1007/s00381-019-04222-z. Epub 2019 May 31.

PMID:
31152217
6.

MN1 rearrangement in astroblastoma: study of eight cases and review of literature.

Mhatre R, Sugur HS, Nandeesh BN, Chickabasaviah Y, Saini J, Santosh V.

Brain Tumor Pathol. 2019 Jul;36(3):112-120. doi: 10.1007/s10014-019-00346-x. Epub 2019 May 20.

PMID:
31111274
7.

Comparative evaluation of cerebral gliomas using rCBV measurements during sequential acquisition of T1-perfusion and T2*-perfusion MRI.

Saini J, Gupta RK, Kumar M, Singh A, Saha I, Santosh V, Beniwal M, Kandavel T, Cauteren MV.

PLoS One. 2019 Apr 24;14(4):e0215400. doi: 10.1371/journal.pone.0215400. eCollection 2019.

8.

High frequency of H3K27M immunopositivity in adult thalamic glioblastoma.

Rao S, Kanuri NN, Nimbalkar V, Arivazhagan A, Santosh V.

Neuropathology. 2019 Apr;39(2):78-84. doi: 10.1111/neup.12537.

PMID:
30937985
9.

ISNO consensus guidelines for practical adaptation of the WHO 2016 classification of adult diffuse gliomas.

Santosh V, Sravya P, Gupta T, Muzumdar D, Chacko G, Suri V, Epari S, Balasubramaniam A, Radotra BD, Chatterjee S, Sarkar C, Jalali R.

Neurol India. 2019 Jan-Feb;67(1):173-182. doi: 10.4103/0028-3886.253572.

10.

Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma.

Arora A, Patil V, Kundu P, Kondaiah P, Hegde AS, Arivazhagan A, Santosh V, Pal D, Somasundaram K.

Sci Rep. 2019 Feb 26;9(1):2749. doi: 10.1038/s41598-019-39067-8.

11.

Transcriptome profiling reveals PDZ binding kinase as a novel biomarker in peritumoral brain zone of glioblastoma.

Kruthika BS, Jain R, Arivazhagan A, Bharath RD, Yasha TC, Kondaiah P, Santosh V.

J Neurooncol. 2019 Jan;141(2):315-325. doi: 10.1007/s11060-018-03051-5. Epub 2018 Nov 20.

PMID:
30460633
12.

L1CAM Immunopositivity in Anaplastic Supratentorial Ependymomas: Correlation With Clinical and Histological Parameters.

Chavali P, Rao S, Palavalasa S, Bevinahalli N, Muthane YTC, Sadashiva N, Santosh V.

Int J Surg Pathol. 2019 May;27(3):251-258. doi: 10.1177/1066896918800812. Epub 2018 Sep 25.

PMID:
30251576
13.

Intracranial Germ Cell Tumors: Spectrum of Disease in an Indian Cohort and Management Strategies.

Borde TD, Arimappamagan A, Srinivas D, Narasinga Rao KVL, Devi BI, Somanna S, Santosh V.

J Neurosci Rural Pract. 2018 Jul-Sep;9(3):291-297. doi: 10.4103/jnrp.jnrp_86_18.

14.

Genetic landscape of long noncoding RNA (lncRNAs) in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma.

Paul Y, Thomas S, Patil V, Kumar N, Mondal B, Hegde AS, Arivazhagan A, Santosh V, Mahalingam K, Somasundaram K.

Oncotarget. 2018 Jul 3;9(51):29548-29564. doi: 10.18632/oncotarget.25434. eCollection 2018 Jul 3.

15.

MGMT promoter methylation in glioblastoma.

Santosh V, Sravya P.

Neurol India. 2018 Jul-Aug;66(4):1115-1116. doi: 10.4103/0028-3886.236995. No abstract available.

16.

Split cord malformation type 1 with two hemicord lesions.

Am U, M B, S D, V S, S S.

Childs Nerv Syst. 2018 Nov;34(11):2313-2316. doi: 10.1007/s00381-018-3835-5. Epub 2018 May 24.

PMID:
29797061
17.

Recurrent Glioblastomas Exhibit Higher Expression of Biomarkers with Stem-like Properties.

Nandeesh BN, Naskar S, Shashtri AH, Arivazhagan A, Santosh V.

J Neurosci Rural Pract. 2018 Jan-Mar;9(1):86-91. doi: 10.4103/jnrp.jnrp_417_17.

18.

Chromosomal aberrations in chordoid meningioma - An analysis.

Sugur H, Shastry AH, Sadashiva N, Srinivas D, Santosh V, Somanna S.

Neurol India. 2018 Jan-Feb;66(1):156-160. doi: 10.4103/0028-3886.222808.

19.

Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.

Saini J, Gupta PK, Sahoo P, Singh A, Patir R, Ahlawat S, Beniwal M, Thennarasu K, Santosh V, Gupta RK.

Neuroradiology. 2018 Jan;60(1):43-50. doi: 10.1007/s00234-017-1942-8. Epub 2017 Oct 31.

PMID:
29090331
20.

Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.

Visvanathan A, Patil V, Arora A, Hegde AS, Arivazhagan A, Santosh V, Somasundaram K.

Oncogene. 2018 Jan 25;37(4):522-533. doi: 10.1038/onc.2017.351. Epub 2017 Oct 9.

PMID:
28991227
21.

Directed evolution provides insight into conformational substrate sampling by SrtA.

Suliman M, Santosh V, Seegar TCM, Dalton AC, Schultz KM, Klug CS, Barton WA.

PLoS One. 2017 Aug 31;12(8):e0184271. doi: 10.1371/journal.pone.0184271. eCollection 2017.

22.

Role of Dynamic Contrast-Enhanced Perfusion Magnetic Resonance Imaging in Grading of Pediatric Brain Tumors on 3T.

Gupta PK, Saini J, Sahoo P, Patir R, Ahlawat S, Beniwal M, Thennarasu K, Santosh V, Gupta RK.

Pediatr Neurosurg. 2017;52(5):298-305. doi: 10.1159/000479283. Epub 2017 Aug 25.

PMID:
28848203
23.

A simple algorithmic approach using histology and immunohistochemistry for the current classification of adult diffuse glioma in a resource-limited set-up.

Rajeswarie RT, Rao S, Nandeesh BN, Yasha TC, Santosh V.

J Clin Pathol. 2018 Apr;71(4):323-329. doi: 10.1136/jclinpath-2017-204638. Epub 2017 Aug 11.

PMID:
28801347
24.

Antipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effects.

Ibi D, de la Fuente Revenga M, Kezunovic N, Muguruza C, Saunders JM, Gaitonde SA, Moreno JL, Ijaz MK, Santosh V, Kozlenkov A, Holloway T, Seto J, García-Bea A, Kurita M, Mosley GE, Jiang Y, Christoffel DJ, Callado LF, Russo SJ, Dracheva S, López-Giménez JF, Ge Y, Escalante CR, Meana JJ, Akbarian S, Huntley GW, González-Maeso J.

Nat Neurosci. 2017 Sep;20(9):1247-1259. doi: 10.1038/nn.4616. Epub 2017 Aug 7.

25.

LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT).

Rao S, Rajeswarie RT, Chickabasaviah Yasha T, Nandeesh BN, Arivazhagan A, Santosh V.

Childs Nerv Syst. 2017 Nov;33(11):1953-1959. doi: 10.1007/s00381-017-3551-6. Epub 2017 Jul 25.

PMID:
28744687
26.

Corrigendum: A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.

Radhakrishnan A, Nanjappa V, Raja R, Sathe G, Puttamallesh VN, Jain AP, Pinto SM, Balaji SA, Chavan S, Sahasrabuddhe NA, Mathur PP, Kumar MM, Prasad TSK, Santosh V, Sukumar G, Califano JA, Rangarajan A, Sidransky D, Pandey A, Gowda H, Chatterjee A.

Sci Rep. 2017 Jun 26;7:46864. doi: 10.1038/srep46864.

27.

Determination of Adeno-associated Virus Rep DNA Binding Using Fluorescence Anisotropy.

Zarate-Perez F, Santosh V, Bardelli M, Agundez L, Linden RM, Henckaerts E, Escalante CR.

Bio Protoc. 2017 Mar 20;7(6). pii: e2194.

28.

Glioma, glutamate (SLC7A11) and seizures-a commentary.

Santosh V, Sravya P.

Ann Transl Med. 2017 May;5(10):214. doi: 10.21037/atm.2017.02.18. No abstract available.

29.

Anaplastic Ependymoma With Ganglionic Differentiation: Report of a Rare Case and Implications in Diagnosis.

Rao S, Ravindra N, Sadashiva N, Indira Devi B, Santosh V.

Int J Surg Pathol. 2017 Oct;25(7):644-647. doi: 10.1177/1066896917710716. Epub 2017 May 29.

PMID:
28554236
30.

Impairments in Quality of Life and Cognitive Functions in Long-term Survivors of Glioblastoma.

Solanki C, Sadana D, Arimappamagan A, Rao KVLN, Rajeswaran J, Subbakrishna DK, Santosh V, Pandey P.

J Neurosci Rural Pract. 2017 Apr-Jun;8(2):228-235. doi: 10.4103/0976-3147.203829.

31.

IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65.

Bhargava S, Visvanathan A, Patil V, Kumar A, Kesari S, Das S, Hegde AS, Arivazhagan A, Santosh V, Somasundaram K.

Oncotarget. 2017 Jun 20;8(25):40469-40485. doi: 10.18632/oncotarget.17118.

32.

Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressor.

Nawaz Z, Patil V, Thinagararjan S, Rao SA, Hegde AS, Arivazhagan A, Santosh V, Somasundaram K.

Mol Oncol. 2017 Aug;11(8):927-944. doi: 10.1002/1878-0261.12060. Epub 2017 May 24.

33.

Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletion.

Santosh V.

Neurol India. 2017 Jan-Feb;65(1):121-122. doi: 10.4103/0028-3886.198196. No abstract available.

34.

PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.

Nawaz Z, Patil V, Paul Y, Hegde AS, Arivazhagan A, Santosh V, Somasundaram K.

Mol Cancer. 2016 Nov 21;15(1):74.

35.

A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.

Radhakrishnan A, Nanjappa V, Raja R, Sathe G, Puttamallesh VN, Jain AP, Pinto SM, Balaji SA, Chavan S, Sahasrabuddhe NA, Mathur PP, Kumar MM, Prasad TS, Santosh V, Sukumar G, Califano JA, Rangarajan A, Sidransky D, Pandey A, Gowda H, Chatterjee A.

Sci Rep. 2016 Oct 31;6:36132. doi: 10.1038/srep36132. Erratum in: Sci Rep. 2017 Jun 26;7:46864.

36.

Granular cells in oligodendroglioma suggest a neoplastic change rather than a reactive phenomenon: case report with molecular characterisation.

Rao S, Sravya P, Chandran C, Saini J, Somanna S, Santosh V.

Brain Tumor Pathol. 2017 Jan;34(1):42-47. doi: 10.1007/s10014-016-0273-5. Epub 2016 Oct 13.

PMID:
27738816
37.

Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastoma.

Pal J, Patil V, Mondal B, Shukla S, Hegde AS, Arivazhagan A, Santosh V, Somasundaram K.

Genes Cancer. 2016 Mar;7(3-4):136-47. doi: 10.18632/genesandcancer.105.

38.

Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription.

Nawaz Z, Patil V, Arora A, Hegde AS, Arivazhagan A, Santosh V, Somasundaram K.

Sci Rep. 2016 Jun 13;6:27753. doi: 10.1038/srep27753.

39.

Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration.

Mondal B, Patil V, Shwetha SD, Sravani K, Hegde AS, Arivazhagan A, Santosh V, Kanduri M, Somasundaram K.

Oncogene. 2017 Jan 5;36(1):71-83. doi: 10.1038/onc.2016.176. Epub 2016 May 23.

PMID:
27212030
40.

Spectrum of primary intracranial tumors at a tertiary care neurological institute: A hospital-based brain tumor registry.

Jaiswal J, Shastry AH, Ramesh A, Chickabasaviah YT, Arimappamagan A, Santosh V.

Neurol India. 2016 May-Jun;64(3):494-501. doi: 10.4103/0028-3886.181535.

41.

Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and contributes to poor patient prognosis.

Patil SS, Gokulnath P, Bashir M, Shwetha SD, Jaiswal J, Shastry AH, Arimappamagan A, Santosh V, Kondaiah P.

Neuro Oncol. 2016 Nov;18(11):1487-1497. Epub 2016 Apr 3.

42.

Functional architecture of the Reb1-Ter complex of Schizosaccharomyces pombe.

Jaiswal R, Choudhury M, Zaman S, Singh S, Santosh V, Bastia D, Escalante CR.

Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):E2267-76. doi: 10.1073/pnas.1525465113. Epub 2016 Mar 28.

43.

Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.

Rajmohan KS, Sugur HS, Shwetha SD, Ramesh A, Thennarasu K, Pandey P, Arivazhagan A, Santosh V.

J Clin Pathol. 2016 Aug;69(8):686-94. doi: 10.1136/jclinpath-2015-203456. Epub 2016 Jan 7.

PMID:
26743027
44.

Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.

Shwetha SD, Shastry AH, Arivazhagan A, Santosh V.

Pathol Res Pract. 2016 Jan;212(1):17-23. doi: 10.1016/j.prp.2015.11.002. Epub 2015 Nov 14.

PMID:
26616112
45.

Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.

Subbannayya T, Leal-Rojas P, Barbhuiya MA, Raja R, Renuse S, Sathe G, Pinto SM, Syed N, Nanjappa V, Patil AH, Garcia P, Sahasrabuddhe NA, Nair B, Guerrero-Preston R, Navani S, Tiwari PK, Santosh V, Sidransky D, Prasad TS, Gowda H, Roa JC, Pandey A, Chatterjee A.

BMC Cancer. 2015 Nov 4;15:843. doi: 10.1186/s12885-015-1855-z.

46.

Imaging characteristics of supratentorial ependymomas: Study on a large single institutional cohort with histopathological correlation.

Mangalore S, Aryan S, Prasad C, Santosh V.

Asian J Neurosurg. 2015 Oct-Dec;10(4):276-81. doi: 10.4103/1793-5482.162702.

47.

Structural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain.

Remesh SG, Santosh V, Escalante CR.

J Biol Chem. 2015 Nov 13;290(46):27779-90. doi: 10.1074/jbc.M115.678789. Epub 2015 Sep 24.

48.

An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals.

Nijaguna MB, Patil V, Hegde AS, Chandramouli BA, Arivazhagan A, Santosh V, Somasundaram K.

PLoS One. 2015 Sep 21;10(9):e0137524. doi: 10.1371/journal.pone.0137524. eCollection 2015.

49.

Nuclear Protein Phosphatase 1 α (PP1A) Expression is Associated with Poor Prognosis in p53 Expressing Glioblastomas.

Shastry AH, Thota B, Srividya MR, Arivazhagan A, Santosh V.

Pathol Oncol Res. 2016 Apr;22(2):287-92. doi: 10.1007/s12253-015-9928-5. Epub 2015 Aug 9.

PMID:
26253838
50.

Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.

Nijaguna MB, Patil V, Urbach S, Shwetha SD, Sravani K, Hegde AS, Chandramouli BA, Arivazhagan A, Marin P, Santosh V, Somasundaram K.

J Biol Chem. 2015 Sep 18;290(38):23401-15. doi: 10.1074/jbc.M115.664037. Epub 2015 Aug 5.

Supplemental Content

Loading ...
Support Center